DCTH
Price:
$11.72
Market Cap:
$404.59M
Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers. Its leading investigational product is the HEPZATO KIT, a unique hepatic delivery system for melphalan that targets high-dose chemotherapy specifically to the liver. This innovative approach aims to substantially reduce systemic drug exposure and mitigate associated side effects. HEPZATO's clinical evaluation is advancing through the FOCUS trial, which is designed to assess the objective response rate in individuals with metastatic uveal melanoma whose disease is primarily concentrated in the liver. Furthermore, t...[Read more]
Industry
Medical - Devices
IPO Date
2018-05-03
Stock Exchange
NASDAQ
Ticker
DCTH
According to Delcath Systems, Inc.’s latest financial reports and current stock price. The company's current ROE is 0.51%. This represents a change of 217.27% compared to the average of 0.16% of the last 4 quarters.
The mean historical ROE of Delcath Systems, Inc. over the last ten years is -521.90%. The current 0.51% ROE has changed -100.10% with respect to the historical average. Over the past ten years (40 quarters), DCTH's ROE was at its highest in in the June 2023 quarter at 2.98%. The ROE was at its lowest in in the December 2017 quarter at -2838.35%.
Average
-521.90%
Median
-17.98%
Minimum
-6654.42%
Maximum
1.21%
Discovering the peaks and valleys of Delcath Systems, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 96.14%
Maximum Annual ROE = 1.21%
Minimum Annual Increase = -805.50%
Minimum Annual ROE = -6654.42%
| Year | ROE | Change |
|---|---|---|
| 2025 | 2.43% | -106.32% |
| 2024 | -38.38% | -87.30% |
| 2023 | -302.20% | -148.50% |
| 2022 | 623.11% | -390.36% |
| 2021 | -214.60% | 96.14% |
| 2020 | -109.41% | -178.33% |
| 2019 | 139.67% | 8.55% |
| 2018 | 128.67% | -101.93% |
| 2017 | -6654.42% | -651.73% |
| 2016 | 1.21% | -805.50% |
The current ROE of Delcath Systems, Inc. (DCTH) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-112.72%
5-year avg
14.07%
10-year avg
-521.90%
Delcath Systems, Inc.’s ROE is less than BrainsWay Ltd. (12.28%), less than Tactile Systems Technology, Inc. (9.70%), greater than NeuroPace, Inc. (-120.74%), greater than RxSight, Inc. (-17.01%), greater than Cerus Corporation (-15.36%), less than Semler Scientific, Inc. (15.65%), greater than 908 Devices Inc. (-25.50%), greater than Agilon Health, Inc. (-146.01%), greater than Senseonics Holdings, Inc. (-130.00%), greater than Nakamoto Inc. (-84.79%),
| Company | ROE | Market cap |
|---|---|---|
| 12.28% | $573.83M | |
| 9.70% | $593.46M | |
| -120.74% | $533.23M | |
| -17.01% | $194.98M | |
| -15.36% | $512.94M | |
| 15.65% | $310.75M | |
| -25.50% | $312.72M | |
| -146.01% | $1.88B | |
| -130.00% | $299.93M | |
| -84.79% | $4.15B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Delcath Systems, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Delcath Systems, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Delcath Systems, Inc.'s ROE?
How is the ROE calculated for Delcath Systems, Inc. (DCTH)?
What is the highest ROE for Delcath Systems, Inc. (DCTH)?
What is the 3-year average ROE for Delcath Systems, Inc. (DCTH)?
What is the 5-year average ROE for Delcath Systems, Inc. (DCTH)?
How does the current ROE for Delcath Systems, Inc. (DCTH) compare to its historical average?